Middle East & Africa Human Microbiome Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

No. of Pages: 129    |    Report Code: BMIRE00032119    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Human Microbiome Market

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. Middle East & Africa Human Microbiome Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Significant Investments by Key Market Players

4.1.2 Government Initiatives

4.2 Market Restraints

4.2.1 Challenges During Production of Microbiome

4.3 Market Opportunities

4.3.1 Robust Investment in Research and Development

4.4 Future Trends

4.4.1 Emergence of Precision Medicine

4.5 Impact of Drivers and Restraints:

5. Human Microbiome Market - Middle East & Africa Analysis

5.1 Middle East & Africa Human Microbiome Market Revenue (US$ Million), 2021-2031

5.2 Middle East & Africa Human Microbiome Market Forecast Analysis

6. Middle East & Africa Human Microbiome Market Analysis - by Type

6.1 Product

6.1.1 Overview

6.1.2 Product: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.2 Software and Services

6.2.1 Overview

6.2.2 Software and Services: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Middle East & Africa Human Microbiome Market Analysis - by Application

7.1 Therapeutics

7.1.1 Overview

7.1.2 Therapeutics: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Diagnostics

7.2.1 Overview

7.2.2 Diagnostics: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Research

7.3.1 Overview

7.3.2 Research: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Human Microbiome Market Analysis - by Disease Type

8.1 Obesity

8.1.1 Overview

8.1.2 Obesity: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Diabetes

8.2.1 Overview

8.2.2 Diabetes: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Autoimmune Disorder

8.3.1 Overview

8.3.2 Autoimmune Disorder: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Cancer

8.4.1 Overview

8.4.2 Cancer: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.5 GIT

8.5.1 Overview

8.5.2 GIT: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Human Microbiome Market - Country Analysis

9.1 Middle East & Africa

9.1.1 Middle East & Africa Human Microbiome Market - Revenue and Forecast Analysis - by Country

9.1.1.1 Middle East & Africa Human Microbiome Market - Revenue and Forecast Analysis - by Country

9.1.1.2 South Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.1.1.2.1 South Africa: Middle East & Africa Human Microbiome Market Share - by Type

9.1.1.2.2 South Africa: Middle East & Africa Human Microbiome Market Share - by Product

9.1.1.2.3 South Africa: Middle East & Africa Human Microbiome Market Share - by Application

9.1.1.2.4 South Africa: Middle East & Africa Human Microbiome Market Share - by Disease Type

9.1.1.3 Saudi Arabia: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.1.1.3.1 Saudi Arabia: Middle East & Africa Human Microbiome Market Share - by Type

9.1.1.3.2 Saudi Arabia: Middle East & Africa Human Microbiome Market Share - by Product

9.1.1.3.3 Saudi Arabia: Middle East & Africa Human Microbiome Market Share - by Application

9.1.1.3.4 Saudi Arabia: Middle East & Africa Human Microbiome Market Share - by Disease Type

9.1.1.4 United Arab Emirates: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.1.1.4.1 United Arab Emirates: Middle East & Africa Human Microbiome Market Share - by Type

9.1.1.4.2 United Arab Emirates: Middle East & Africa Human Microbiome Market Share - by Product

9.1.1.4.3 United Arab Emirates: Middle East & Africa Human Microbiome Market Share - by Application

9.1.1.4.4 United Arab Emirates: Middle East & Africa Human Microbiome Market Share - by Disease Type

9.1.1.5 Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market Share - by Type

9.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market Share - by Product

9.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market Share - by Application

9.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market Share - by Disease Type

10. Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Human Microbiome Market

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Inorganic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 MaaT Pharma

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Ferring Holdings SA

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 AOBiome Therapeutics Inc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Finch Therapeutics Group Inc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Financial Overview

11.4.4 SWOT Analysis

11.4.5 Key Developments

11.5 Seres Therapeutics Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Merck & Co Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Yakult Honsha Co., Ltd.

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Rebiotix, Inc.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 IFF Nutrition & Biosciences

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Synthetic Biologics, Inc.

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About Us

12.2 List of Abbreviations

 

List of Tables

Table 1. Middle East & Africa Human Microbiome Market Segmentation

Table 2. Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Table 3. Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type

Table 4. Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application

Table 5. Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease Type

Table 6. Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country

Table 7. South Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type

Table 8. South Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 9. South Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 10. South Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type

Table 11. Saudi Arabia: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type

Table 12. Saudi Arabia: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 13. Saudi Arabia: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 14. Saudi Arabia: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type

Table 15. United Arab Emirates: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type

Table 16. United Arab Emirates: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 17. United Arab Emirates: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 18. United Arab Emirates: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type

Table 19. Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type

Table 20. Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 21. Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 22. Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease Type

Table 23. Recent Organic Growth Strategies in the Human Microbiome Market

Table 24. Recent Inorganic Growth Strategies in the Human Microbiome Market

Table 25. List of Abbreviations

 

List of Figures

Figure 1. Middle East & Africa Human Microbiome Market Segmentation - Country

Figure 2. Middle East & Africa Human Microbiome Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Human Microbiome Market Revenue (US$ Million), 2021-2031

Figure 5. Middle East & Africa Human Microbiome Market Share (%) - by Type (2023 and 2031)

Figure 6. Product: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 7. Software and Services: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 8. Middle East & Africa Human Microbiome Market Share (%) - by Application (2023 and 2031)

Figure 9. Therapeutics: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 10. Diagnostics: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 11. Research: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 12. Middle East & Africa Human Microbiome Market Share (%) - by Disease Type (2023 and 2031)

Figure 13. Obesity: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 14. Diabetes: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 15. Autoimmune Disorder: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 16. Cancer: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 17. GIT: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 18. Others: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 19. Middle East & Africa Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 20. South Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 21. Saudi Arabia: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 22. United Arab Emirates: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 23. Rest of Middle East & Africa: Middle East & Africa Human Microbiome Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 24. Growth Strategies in the Human Microbiome Market

 

The List of Companies - Middle East & Africa Human Microbiome Market

  • MaaT Pharma
  • Ferring Holdings SA
  • AOBiome Therapeutics Inc
  • Finch Therapeutics Group Inc
  • Seres Therapeutics Inc
  • Merck & Co Inc
  • Rebiotix, Inc.
  • Yakult Honsha Co., Ltd.
  • IFF Nutrition & Biosciences
  • Synthetic Biologics, Inc.